283 related articles for article (PubMed ID: 8821056)
1. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
Kupsch A; Oertel WH; Earl CD; Sautter J
J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
[TBL] [Abstract][Full Text] [Related]
2. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
Mínguez-Castellanos A; Escamilla-Sevilla F
Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
4. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
Mínguez-Castellanos A; Escamilla-Sevilla F
Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
[TBL] [Abstract][Full Text] [Related]
6. Emerging restorative treatments for Parkinson's disease.
Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
[TBL] [Abstract][Full Text] [Related]
7. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
8. [Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
Sautter J; Kupsch A; Oertel WH; Earl CD
Zentralbl Neurochir; 1995; 56(4):161-7. PubMed ID: 8571694
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
Tatard VM; Sindji L; Branton JG; Aubert-Pouëssel A; Colleau J; Benoit JP; Montero-Menei CN
Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
[TBL] [Abstract][Full Text] [Related]
10. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
Ahn YH; Bensadoun JC; Aebischer P; Zurn AD; Seiger A; Björklund A; Lindvall O; Wahlberg L; Brundin P; Kaminski Schierle GS
Brain Res Bull; 2005 Jul; 66(2):135-42. PubMed ID: 15982530
[TBL] [Abstract][Full Text] [Related]
11. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
12. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
13. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
14. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
Yurek DM
Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
[TBL] [Abstract][Full Text] [Related]
15. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
16. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
17. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
Yasuhara T; Date I
Cell Transplant; 2007; 16(2):125-32. PubMed ID: 17474294
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
19. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease.
Lapchak PA
Mov Disord; 1998; 13 Suppl 1():49-54. PubMed ID: 9613719
[TBL] [Abstract][Full Text] [Related]
20. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
